Atomera Inc (ATOM) Q1 2026 Earnings Call Transcript

Why It Matters

Technical validation positions Atomera to monetize MST through high‑volume GAA chips, a fast‑growing segment, while its limited cash and rising expenses make near‑term licensing deals critical.

Key Takeaways

• FY2025 revenue $65k, GAAP loss $20.2M.
• MST validated in GAA nanosheet structures.
• OEM partnership targets TSMC, Samsung, Intel, Japanese foundry.
• GaN‑on‑silicon project receives Power America approval.
• ATM sales raised $10.8M, cash $19.2M year‑end.

Pulse Analysis

Atomera’s FY 2025 financials underscore a classic early‑stage materials play: revenue remains negligible at $65 k, while GAAP losses widened to $20.2 million. The company’s cash balance fell to $19.2 million after a $14.9 million operating outflow, but an at‑the‑market offering generated $10.8 million of fresh capital. Management’s decision to withhold $669 k of executive bonuses and to project non‑GAAP operating expenses of $18.5 million for 2026 reflects a disciplined approach to cash preservation as it ramps up commercialization activities.

The centerpiece of Atomera’s narrative is the definitive silicon validation of its Mears Silicon Technology in gate‑all‑around (GAA) nanosheet transistors. By demonstrating superior diffusion‑blocking performance on real‑world advanced‑node structures, MST becomes a viable add‑on for the industry’s most demanding AI and logic chips. A strategic partnership with a major equipment OEM, aimed at TSMC, Samsung, Intel and a Japanese foundry, gives Atomera direct access to the manufacturing pipelines that will drive volume adoption, potentially unlocking a multi‑billion‑dollar addressable market.

Beyond GAA, Atomera is expanding its footprint across DRAM, RF‑SOI, power and GaN segments. Wafer‑based solutions promise faster integration for customers, while internal simulations suggest over 40 % performance gains for TrenchFET power devices. The recent approval of a GaN‑on‑silicon project by Power America introduces government‑funded development capital and validates market interest. As the company adds senior sales leadership and records a surge in wafer runs, the next 12‑18 months will be pivotal for converting technical milestones into licensing revenue and establishing Atomera as a material supplier in the next generation of semiconductor manufacturing.